Guan Wang

9.1k total citations · 5 hit papers
216 papers, 5.9k citations indexed

About

Guan Wang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Guan Wang has authored 216 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 38 papers in Oncology and 24 papers in Organic Chemistry. Recurrent topics in Guan Wang's work include Autophagy in Disease and Therapy (17 papers), Protein Degradation and Inhibitors (17 papers) and Histone Deacetylase Inhibitors Research (13 papers). Guan Wang is often cited by papers focused on Autophagy in Disease and Therapy (17 papers), Protein Degradation and Inhibitors (17 papers) and Histone Deacetylase Inhibitors Research (13 papers). Guan Wang collaborates with scholars based in China, United States and Thailand. Guan Wang's co-authors include Liang Ouyang, Richard Kendall, Kenneth A. Thomas, Bo Liu, Lu Feng, Lan Zhang, Junping Pei, Jifa Zhang, Yuan Liu and Haiyan Zhang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Guan Wang

213 papers receiving 5.8k citations

Hit Papers

Identification of a Natural Soluble Form of the Vascular ... 1996 2026 2006 2016 1996 2021 2022 2024 2024 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guan Wang China 40 3.2k 924 749 686 621 216 5.9k
Yanmin Zhang China 48 4.1k 1.3× 777 0.8× 1000 1.3× 389 0.6× 360 0.6× 434 8.5k
Qiang Shen China 52 3.8k 1.2× 1.5k 1.6× 1.2k 1.6× 674 1.0× 1.1k 1.7× 257 9.1k
Yan Li China 46 3.7k 1.2× 1.4k 1.6× 1.3k 1.7× 596 0.9× 357 0.6× 379 7.9k
Xin Wang China 45 2.8k 0.9× 1.6k 1.7× 599 0.8× 1.0k 1.5× 338 0.5× 402 8.0k
Xiaodong Wang China 44 4.7k 1.5× 476 0.5× 1.4k 1.9× 452 0.7× 619 1.0× 308 8.7k
Yuwei Wang China 47 3.5k 1.1× 814 0.9× 1.4k 1.9× 877 1.3× 481 0.8× 362 7.7k
Lili Zhou China 49 4.1k 1.3× 578 0.6× 859 1.1× 674 1.0× 711 1.1× 295 8.8k
Jian Chen China 42 3.5k 1.1× 535 0.6× 1.3k 1.8× 344 0.5× 509 0.8× 329 7.0k
Jie Lu China 45 2.9k 0.9× 819 0.9× 1.1k 1.5× 344 0.5× 1.1k 1.7× 170 5.9k
Jing Liu China 36 2.9k 0.9× 556 0.6× 548 0.7× 444 0.6× 183 0.3× 251 5.6k

Countries citing papers authored by Guan Wang

Since Specialization
Citations

This map shows the geographic impact of Guan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guan Wang more than expected).

Fields of papers citing papers by Guan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guan Wang. The network helps show where Guan Wang may publish in the future.

Co-authorship network of co-authors of Guan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guan Wang. A scholar is included among the top collaborators of Guan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guan Wang. Guan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wenbo, et al.. (2025). Novel gut-restricted bivalent agonists targeting mucosal 5-HT4R: Design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 289. 117425–117425. 1 indexed citations
2.
Zhang, Xuping, Zhong-guo Fu, Zhihao Fang, et al.. (2025). The strain rate effect on strength behavior of CoCrNi medium entropy alloy up to 106 s−1. Intermetallics. 179. 108665–108665. 3 indexed citations
3.
Wang, Yu, Ping Yan, Guan Wang, et al.. (2024). Trajectory on postpartum depression of Chinese women and the risk prediction models: A machine-learning based three-wave follow-up research. Journal of Affective Disorders. 365. 185–192. 6 indexed citations
4.
Wu, Yongya, Xiaoli Pan, Shuai Wen, et al.. (2024). Autophagy modulation in cancer therapy: Challenges coexist with opportunities. European Journal of Medicinal Chemistry. 276. 116688–116688. 9 indexed citations
5.
Wu, Yongya, Yuan Hu, Shuai Wen, et al.. (2024). Small molecule inhibitors targeting m6A regulators. Journal of Hematology & Oncology. 17(1). 30–30. 24 indexed citations
6.
Mou, Yi, et al.. (2024). Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer. Medicinal Research Reviews. 44(6). 2600–2623. 13 indexed citations
7.
Wan, Long, et al.. (2023). Effects of rock lithology and soil nutrients on nitrogen and phosphorus mobility in trees in non-karst and karst forests of southwest China. Forest Ecology and Management. 548. 121392–121392. 12 indexed citations
8.
Zhang, Xiaojuan, Jia Chen, Guan Wang, et al.. (2023). Identification of HHT-9041P1: A novel potent and selective JAK1 inhibitor in a rat model of rheumatoid arthritis. International Immunopharmacology. 125(Pt A). 111086–111086. 1 indexed citations
9.
Xu, Xin, Guan Wang, Qiang Li, et al.. (2023). Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2). Bioorganic & Medicinal Chemistry Letters. 97. 129558–129558. 4 indexed citations
10.
Xiao, Huan, et al.. (2023). Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?. European Journal of Medicinal Chemistry. 248. 115104–115104. 5 indexed citations
11.
13.
Li, Yang, et al.. (2023). Small molecules targeting protein–protein interactions for cancer therapy. Acta Pharmaceutica Sinica B. 13(10). 4060–4088. 36 indexed citations
14.
Li, Yang, et al.. (2023). Development of covalent inhibitors: Principle, design, and application in cancer. SHILAP Revista de lepidopterología. 2(4). 32 indexed citations
15.
16.
Li, Jia, Guan Wang, Qin Yu, et al.. (2020). Neuroprotective constituents from the aerial parts of Cannabis sativa L. subsp. sativa. RSC Advances. 10(53). 32043–32049. 8 indexed citations
17.
Zang, Yuan‐Sheng, Chun Dai, Xiaoman Xu, et al.. (2019). Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer. Cancer Medicine. 8(10). 4699–4708. 48 indexed citations
18.
Wang, Guan, Kai Cao, Keli Liu, et al.. (2017). Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death and Differentiation. 25(7). 1209–1223. 163 indexed citations
19.
Li, Yuanyuan, et al.. (2009). Lanostanoids Isolated from Ganoderma lucidum Mycelium Cultured by Submerged Fermentation. Helvetica Chimica Acta. 92(8). 1586–1593. 14 indexed citations
20.
Wang, Guan. (2001). Cloning and Sequencing the Full-length cDNA of Annexin from Strawberry Fruit. Journal of Integrative Plant Biology. 43(8). 874–876. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026